Report overview
This report contains market size and forecasts of Circulating Tumor Cell Detector in global, including the following market information:
Global Circulating Tumor Cell Detector Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Circulating Tumor Cell Detector Market Sales, 2018-2023, 2023-2030, (Units)
Global top five Circulating Tumor Cell Detector companies in 2022 (%)
The global Circulating Tumor Cell Detector market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
CTC Enrichment Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Circulating Tumor Cell Detector include Menarini-Silicon Biosystems, Qiagen, Advanced Cell Diagnostics, ApoCell, Epic Sciences, Greiner Bio-one, Cynvenio, SurExamBio-Tech and Fluxion Biosciences, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Circulating Tumor Cell Detector manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Circulating Tumor Cell Detector Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (Units)
Global Circulating Tumor Cell Detector Market Segment Percentages, by Type, 2022 (%)
CTC Enrichment
CTC Detection
CTC Analysis
Global Circulating Tumor Cell Detector Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Units)
Global Circulating Tumor Cell Detector Market Segment Percentages, by Application, 2022 (%)
Clinical Application
Scientific Research
Global Circulating Tumor Cell Detector Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Units)
Global Circulating Tumor Cell Detector Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Circulating Tumor Cell Detector revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Circulating Tumor Cell Detector revenues share in global market, 2022 (%)
Key companies Circulating Tumor Cell Detector sales in global market, 2018-2023 (Estimated), (Units)
Key companies Circulating Tumor Cell Detector sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Menarini-Silicon Biosystems
Qiagen
Advanced Cell Diagnostics
ApoCell
Epic Sciences
Greiner Bio-one
Cynvenio
SurExamBio-Tech
Fluxion Biosciences
Ikonisys
Hangzhou Watson Biotech
Biocept
CytoTrack
Celsee
ANGLE
